| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 10/10/2007 | EP1624897B1 Hiv prodrugs cleavable by cd26 |
| 10/09/2007 | US7279458 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid |
| 10/04/2007 | WO2007112348A2 Prodrug composition |
| 10/04/2007 | WO2007111952A2 Method of preparing glycopeptides |
| 10/04/2007 | US20070232537 Intranasal pyy formulations with improved transmucosal pharmacokinetics |
| 10/02/2007 | US7276475 Remodeling and glycoconjugation of peptides |
| 09/26/2007 | EP1417223B1 Process for preparing lipid ii |
| 09/25/2007 | US7273845 vancomycin-polymer conjugate; polymer is attached to both of the vancomycin amino groups |
| 09/20/2007 | US20070219123 Selective n-acylation of a82846 glycopeptide analogs |
| 09/05/2007 | CN101031582A Purification of glycopeptides |
| 09/04/2007 | US7265096 treat or prevent diseases or disorders such as cancer or viral infections |
| 09/04/2007 | US7265086 Useful as antibacterial agents |
| 09/04/2007 | US7265085 Glycoconjugation methods and proteins/peptides produced by the methods |
| 08/30/2007 | WO2007096517A1 Presentation of recognition motifs by a multivalent matrix grafted onto a solid support |
| 08/30/2007 | US20070203056 novel antiproliferative factor and methods of use |
| 08/30/2007 | US20070203054 Fragments of nkp44 for targeting viral-infected and tumor cells |
| 08/30/2007 | CA2643042A1 Presentation of recognition motifs by a multivalent matrix grafted onto a solid support |
| 08/29/2007 | EP1824874A1 Pure vancomycin hydrochloride |
| 08/28/2007 | US7262177 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
| 08/28/2007 | US7262040 Incorporating into a protein an unnatural amino acid that has a saccharide moiety using an orthogonal tRNA/orthogonal aminoacyl-tRNA synthetase (O-tRNA/O-RS) pair, and contacting the saccharide moiety with a recombinant glycosyltransferase and a sugar donor to transfer a sugar to the saccharide moiety |
| 08/23/2007 | US20070197465 Hyaluronic Acid-Methotrexate Conjugate |
| 08/22/2007 | EP1819723A2 Drug delivery peptides for crossing blood-brain barrier |
| 08/21/2007 | US7259141 prepared via chemoenzymatic techniques; contain a 1,2,3-triazole moeity attached to the sugar group; glycosylating a vancomycin aglycone with a sugar transferase, then reacting with an alkyne via a 1,3-dipolar cycloaddition; treating vancomycin resistant infections |
| 08/21/2007 | CA2178517C Neisseria meningitidis capsular polysaccharide conjugates |
| 08/15/2007 | EP1818340A1 Glycopeptide antibiotic monomer derivatives |
| 08/15/2007 | EP1817329A1 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery |
| 08/14/2007 | US7256268 Human high affinity choline transporter |
| 08/14/2007 | US7256254 For therapy and prophylaxis of myocarditis |
| 08/09/2007 | US20070185015 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 08/09/2007 | US20070184517 Pharmacokinetics; glycosyltransferases; antibodies; immunoglobulins |
| 08/07/2007 | CA2115565C Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 08/01/2007 | CN1329397C Cross-linked glycopeptide-cephalosporin antibiotics |
| 07/26/2007 | US20070173636 Reacting a peptide acyl donor comprising a peptidic backbone made up of two or more amino acids with a peptide amine acceptor under reducing reaction conditions employing an excess of a reducing agent; |
| 07/26/2007 | US20070172915 Glycoprotein synthesis |
| 07/26/2007 | US20070172422 Exponential pattern recognition based cellular targeting compositions, methods and anticancer applications |
| 07/26/2007 | CA2637730A1 Soluble fragments of the sars-cov spike glycoprotein |
| 07/19/2007 | US20070167356 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 07/19/2007 | US20070167354 Hydrogels for modulating cell migration and matrix deposition |
| 07/19/2007 | US20070167353 Prodrug composition |
| 07/18/2007 | EP1558747A4 Glycoprotein synthesis |
| 07/17/2007 | US7244705 Polyacid glycopeptide derivatives |
| 07/17/2007 | CA2216167C Glycopeptide antibiotic derivatives |
| 07/11/2007 | EP1805211A1 Purification of glycopeptides |
| 07/04/2007 | EP1470141A4 Glycosulfopeptide inhibitors and methods of use thereof |
| 07/03/2007 | US7238510 Glycoprotein synthesis |
| 06/28/2007 | US20070149441 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| 06/28/2007 | CA2633801A1 Cyclodextrin-containing polymers and uses thereof |
| 06/26/2007 | US7235650 Having substituents such as steroids, reporter molecules/enzymes, non-aromatic lipophilic molecules, peptides, or proteins attached via linking groups; improved diagnosis |
| 06/26/2007 | CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 06/21/2007 | WO2007068644A1 Process for the purification of macrolide antibiotics |
| 06/21/2007 | CA2628798A1 Process for the purification of macrolide antibiotics |
| 06/20/2007 | EP1798237A1 Process for the purification of macrolide antibiotics |
| 06/13/2007 | EP1793812A2 Antibiotic compound |
| 06/13/2007 | EP0680512B1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
| 06/07/2007 | WO2000044335A3 Uridyl peptide antibiotic (upa) derivatives, their synthesis and use |
| 06/05/2007 | US7226904 Agents and methods for promoting bone growth |
| 06/05/2007 | US7226903 Interferon beta: remodeling and glycoconjugation of interferon beta |
| 05/31/2007 | WO2005070138A3 O-linked glycosylation of peptides |
| 05/29/2007 | US7223845 Which have one or more sulfated tyrosine residues and a glycan linked to the peptide, the glycan preferably including a sialyl Lewisx group or a sialyl Lewisa group; antiinflammatory, antithrombotic, antimetastatic compounds |
| 05/24/2007 | US20070116644 Detectable labeled cobalamin (adenosylcolbalamin) conjugated with peptidesor amino acid residues linked to a chelate compound (ETDA) including a metal radionuclide;antitumor, anticarcinogenic agents; contrast agent for imaging; diagnosis; nontoxic;bioavailability; detectable at low concentrations |
| 05/18/2007 | WO2007054717A2 STAUROSPORINE DERIVATIVES FOR THE TREATMENT OF LEUKEMIA CHARACTERISED BY A SPTBNl -FLT3 MUTATION |
| 05/16/2007 | CN1964736A Dalbavancin compositions for treatment of bacterial infections |
| 05/15/2007 | US7217809 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits |
| 05/15/2007 | CA2394616C Gene cluster for ramoplanin biosynthesis |
| 05/09/2007 | EP1073447B1 N1-modified glycopeptides |
| 05/03/2007 | US20070098730 using a glycoconjugate comprising a dendrimeric or linear poly-Lysine enabling multiple epitopes to be covalently attached thereto; anticancer or antitumor agents |
| 05/02/2007 | EP1418933B1 Process for preparing glycopeptide phosphonate derivatives |
| 04/25/2007 | EP0984023B1 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/24/2007 | US7208471 Glycopeptide phosphonate derivatives |
| 04/18/2007 | EP1575990A4 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 04/18/2007 | EP1419174B1 Process for preparing glycopeptide derivatives |
| 04/17/2007 | CA2123912C Muramyl compounds for treatment of septic shock |
| 04/11/2007 | CN1946743A Hyaluronic acid/methotrexate compound |
| 04/03/2007 | US7199222 An artificial mutant tRNA synthetase; aminoacylates an orthogonal tRNA with beta -GlcNAc-serine |
| 03/28/2007 | EP1765853A2 O-linked glycosylation of peptides |
| 03/27/2007 | US7195880 DNA-protein fusions and uses thereof |
| 03/20/2007 | US7193034 Synthetic peptides, conjugation reagents and methods |
| 03/20/2007 | US7192743 applying solutions comprising culture broths containing teicoplanin, from Actinoplanes teichomyceticus strains capable of producing teicoplanin, to porous adsorption resins, then eluting, treating with activated carbon to recover the teicoplanin andultrafiltration; purification |
| 03/20/2007 | CA2223080C Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2,5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 03/14/2007 | CN1930182A Antithrombotic compound |
| 03/13/2007 | US7189828 use of glycopeptides containing sulfated tyrosines and sialyated, fucosylated N-acetyllactosamino glycans; for treating inflammation, ischemia-reperfusion injury, rheumatoid arthritis, atherosclerosis, leukocyte-mediated lung injury, restenosis, and thrombosis |
| 03/13/2007 | US7189691 Methods and compositions for treating leukemia |
| 03/07/2007 | CN1925841A Pharmaceutical preparation for the oral cavity |
| 03/06/2007 | CA2141670C Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 03/01/2007 | US20070049519 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals |
| 02/28/2007 | EP1276491B9 Tamandarin and didemnin analogs and methods of making and using them |
| 02/27/2007 | US7183253 Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 |
| 02/27/2007 | US7183082 in vitro and in vivo; involves incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics |
| 02/22/2007 | US20070042942 Glycopeptide carboxy-saccharide derivatives |
| 02/22/2007 | US20070041986 Synthetic polysaccharide antigens for immunological intervention in disease |
| 02/21/2007 | EP1137812B1 Dna-protein fusions and uses thereof |
| 02/21/2007 | CN1916021A Amido glycoside of sea pearl oyster, prepartion method, and usage |
| 02/20/2007 | US7179617 Forming a convalent conjugate of a Factor IX peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 02/20/2007 | CA2251086C Glycopeptide compounds |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032407 Use treating hepatitis C infection optionally with other viricides such as interferons or ribavirin; low toxicity to the host; use of cytosine-based nucleotides or nucleosides having a 2'-trifluoromethyl-ribose moiety which forms a 5'-phosphate or hydroxy moiety in vivo |
| 02/08/2007 | US20070032405 Branched water-soluble polymers and their conjugates |
| 02/08/2007 | US20070031380 Integration-site directed vector systems |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/07/2007 | EP1748786A2 Dalbavancin compositions for treatment of bacterial infections |